10.06.2011 • NewsDIDPGlaxoSmithKline (GSK)GSK

Hong Kong Orders GSK To Recall Antibiotic Due to Plasticizer

Hong Kong has ordered GlaxoSmithKline(GSK) to recall an pediatric antibiotic manufactured in France over the presence of a plasticizer in the product, raising safety and quality concerns.       

The Department of Health said in a statement that diisodecyl phthalate (DIDP) was detected in GSK's Augmentin powder for syrup 156mg/5ml, a product for children.  A government laboratory test detected the presence of DIDP was two times higher than Europe's specific migration limit for food contact materials.

DIDP's safety for human consumption was not well established, but data from animal studies suggested long-term consumption of high levels of DIDP may affect the liver, the government said.      

The government said it had stepped up surveillance of pharmaceutical products containing flavoring agents after  Chinese media reports that Chinese importers had recalled bottled beverages from Taiwan that were suspected of being contaminated with a cancer-causing plastic additive.

 

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.